SYNLOGIC, INC. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
SYNLOGIC, INC. (SYBX) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 6.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2026-03-12
- SYNLOGIC, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2021 was 6.00%, a 50.00% increase from fiscal 2020.
- SYNLOGIC, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2020 was 4.00%, a 0.00% change from fiscal 2019.
- SYNLOGIC, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2019 was 4.00%.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|
| 2021-12-31 | 6.00% 10-K · filed 2026-03-12 |
| 2020-12-31 | 4.00% 10-K · filed 2026-03-12 |
| 2019-12-31 | 4.00% 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |